One way scientists are working to overcome challenges in cancer treatment and improve cancer care is through nanotechnology. Nanotechnology, engineered materials that make use of the unique physical properties, presents a new array of medical prospects that will revolutionize cancer prevention, diagnosis, and treatment practices. Giving new hope to patients, practitioners, and researchers alike, nanotechnology has the potential to translate recent discoveries in cancer biology into clinical advances in oncology. While public investments in nanotechnology for cancer continue to increase, medical products based on nanotechnology are already on the market. The National Cancer Policy forum held a workshop July 12-13, 2010, to explore challenges in the use of nanotechnology in oncology. Nanotechnology and Oncology evaluates the ongoing discussion on the role of nanotechnology in cancer as it relates to risk management, treatment, and regulatory policy. Assessments on nanomedicine and the physical properties of nanomaterials were presented during the workshop, along with an appraisal of the current status of research and development efforts.


![[PDF] On Being a Scientist: A Guide to Responsible Conduct in Research: Third Edition Engineering, and Public Policy Committee on Science, National Academy of Sciences, National Academy of Engineering, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/bebe52473d9b2bc6b9fb5eaeb76a8954-d-247x296.jpg)
![[PDF] Examining Core Elements of International Research Collaboration: Summary of a Workshop Planning Committee for the Workshop on Examining Core Elements of International Collaboration, Government-University-Industry Research Roundtable, Policy and Global Affairs, National Academy of Sciences, National Academy of Engineering, Institute of Medicine, National Academies](https://digzon.com/wp-content/uploads/2024/04/a9b9db48499d3922735bc14b92026e3f-g-247x296.jpg)
![[PDF] 2008 Amendments to the National Academies' Guidelines for Human Embryonic Stem Cell Research Human Embryonic Stem Cell Research Advisory Committee, National Research Council, Institute of Medicine, National Academies](https://digzon.com/wp-content/uploads/2024/04/266bcf8509c7558de3673f1cd4917916-d-247x296.jpg)
![[PDF] Corporate Restructuring and Industrial Research and Development The Academy Industry Program of the National Academy of, National Academy of Engineering, Institute of Medicine](https://digzon.com/wp-content/uploads/2024/04/d2935cd8c4c6572d459316429d08d607-d.jpg)
Reviews
There are no reviews yet.